Skip to main content

China Medical System Holdings

China Medical System Holdings Limited, commonly known as CMS, is a specialty pharmaceutical service provider in China focused on product licensing, promotion, and sales. The company identifies, acquires, and commercializes specialty prescription drugs and aesthetic medical products across therapeutic fields such as cardiology, gastroenterology, dermatology, and ophthalmology. Revenue is predominantly derived from commercial product sales of licensed proprietary pharmaceuticals and medical aesthetic treatments to hospital and pharmacy distribution networks. CMS serves pharmaceutical brand owners, hospital networks, specialty medical clinics, dermatology practices, and retail pharmacies across mainland China and international markets. The enterprise holds an established market position as a premier specialty pharmaceutical commercialization platform in Greater China. China Medical System Holdings Limited is headquartered in Shenzhen, China, and its common shares are listed on the Stock Exchange of Hong Kong.

7 of the funds FundTelligence covers report a position in China Medical System Holdings.

Legal name
China Medical System Holdings Ltd
Sector
Health Care
Country
China
Funds holding it
7

Funds holding China Medical System Holdings

Loading...